"LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept"
NICE recommends regular monitoring including HbA1c, weight, and renal function
Convenient daily use
Yes, and more are on the way More convenient and needle-free GLP-1 options are coming, and the studies show they are as effective, if not more, compared to GLP-1 injectables Does the thought of injecting medication into your body send shivers down your spine
Shotsy keeps tracking costs low Shotsy is free to download with a generous free tier that includes dose logging, weight tracking, side effect logging, nutrition tracking, and PDF export for providers